BELLFORMIN Tablets 500 Milligram
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
01-04-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
METFORMIN HYDROCHLORIDE
Available from:
BellPharma Limited
Dosage:
500 Milligram
Pharmaceutical form:
Tablets
Authorization date:
1999-12-10
Summary of Product characteristics
License
Part II
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Bellformin 500 mg Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains:
Metformin hydrochloride 500 mg.
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablets
White coloured, round, biconvex tablets.
4 CLINICAL PARTICULARS
4.1 Therapeutic Indications
Non-insulin-dependent diabetes (NIDDM, type II), when adequate dietary treatment has failed.
Bellformin 500mg tablets can be given alone as initial therapy, or can be administered in combination with
sulphonylureas after careful assessment of the contraindications.
4.2 Posology and method of administration
Dosage
Usual dosage:
The required daily dose ranges from 0.5 to 3g (1-6 tablets). Therapy should be initiated with a low dose of one or two
tablets daily. Depending on the metabolic state the dose can be increased stepwise at intervals of a few days up to two
weeks until the therapeutically required dose has been reached. In order to minimise the gastro-intestinal side-effects
the daily dose should be divided and taken with or after meals. Generally, daily doses of 1.5g (three tablets) are
sufficient. If diabetic control is incomplete a cautious increase in
Read the complete document
